Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Strata Critical Medical, Inc. (SRTA)

4.6350 -0.1150 (-2.42%)
As of 10:02:33 AM EDT. Market Open.
Trade SRTA on Coinbase
Chart Range Bar
Loading chart for SRTA
  • Previous Close 4.7500
  • Open 4.7000
  • Bid 3.3200 x 200
  • Ask 5.9200 x 200
  • Day's Range 4.5900 - 4.7250
  • 52 Week Range 3.9500 - 6.5000
  • Volume 225,978
  • Avg. Volume 914,675
  • Market Cap (intraday) 410.044M
  • Beta (5Y Monthly) 2.43
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2800
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 9.56
  • Zacks Rating Neutral

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

www.stratacritical.com

327

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SRTA
3.64%
S&P 500 (^GSPC)
11.41%

1-Year Return

SRTA
8.94%
S&P 500 (^GSPC)
11.79%

3-Year Return

SRTA
110.68%
S&P 500 (^GSPC)
83.03%

5-Year Return

SRTA
51.06%
S&P 500 (^GSPC)
65.60%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 72.51M
Earnings -10.52M
Profit Margin -14.50%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20M
40M
60M
-15.0%
-10.0%
-5.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

8.00
9.56 Average
4.6350 Current
12.75 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 3/25/2026
Analyst Craig-Hallum
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 8

Statistics

View More

Valuation Measures

Annual
As of 10/29/2026
  • Market Cap

    419.33M

  • Enterprise Value

    400.83M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    1.57

  • Price/Book (mrq)

    1.50

  • Enterprise Value/Revenue

    1.57

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.71%

  • Return on Assets (ttm)

    -1.86%

  • Return on Equity (ttm)

    -9.22%

  • Revenue (ttm)

    255.98M

  • Net Income Avi to Common (ttm)

    -23.16M

  • Diluted EPS (ttm)

    -0.2800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.75M

  • Total Debt/Equity (mrq)

    1.52%

  • Levered Free Cash Flow (ttm)

    -20.09M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

4.6350 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: